PF-07985631

DRUG2 trials

Sponsors

Pfizer

Conditions

Healthy

Phase 1

A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults

RecruitingNCT06994897

Start: 2025-08-13End: 2027-12-08Target: 92Updated: 2026-03-20

A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults

TerminatedNCT07235150

Start: 2025-12-11End: 2026-07-16Updated: 2026-08-18